Evaluation of a mobile application to decrease opioid misuse in patients undergoing cesarean section: a randomized controlled trial
Abstract Background Opioid misuse and addiction are at epidemic levels in the United States. Postoperative opioid prescription is inconsistent and often excessive, including for cesarean section patients. Technology, such as mobile applications and clinical decision support tools, can be used to dec...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-12-01
|
| Series: | BMC Pregnancy and Childbirth |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12884-024-06953-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850169426448482304 |
|---|---|
| author | Annabelle Abdo Mariel O’Connor Jessica Kelley Morgan Laura Hart Alexa Leib Steven K. Walther Andy Tang Gail Herrine |
| author_facet | Annabelle Abdo Mariel O’Connor Jessica Kelley Morgan Laura Hart Alexa Leib Steven K. Walther Andy Tang Gail Herrine |
| author_sort | Annabelle Abdo |
| collection | DOAJ |
| description | Abstract Background Opioid misuse and addiction are at epidemic levels in the United States. Postoperative opioid prescription is inconsistent and often excessive, including for cesarean section patients. Technology, such as mobile applications and clinical decision support tools, can be used to decrease opioid use and misuse among patients, and to determine more appropriate prescribing practices for specific procedures. The objective of this study was to examine the preliminary impact of the Continuing Precision Medicine (CPM) mobile application to reduce the use of opioid pain medication among women who underwent cesarean section. The primary outcome is morphine milligram equivalents (MME), while the secondary outcomes will be delay to dosages, decrease of usage, and pain scores. Methods Patients undergoing cesarean section were randomized to either a control group or an experimental group, which used the CPMRx mobile app to help manage postoperative pain. Logistic regression analyses were run to predict opioid misuse by group (control [electronic monitoring blister pack only] versus CPMRx [electronic monitoring blister pack plus mobile application]) and odds ratios (ORs) were calculated. Relative risk (RR) was also estimated by log-binomial regression. Results In phase I, 105 patients were assessed for eligibility, however, 66 were excluded (not meeting criteria or declined to participate). In phase 2, 98 patients were assessed for eligibility, however, 48 were excluded for the aforementioned. Results of the logistic regression showed that opioid misuse differed significantly by group (χ2 = 7.27, p = 0.007) with participants in the CPMRx group experiencing a 92% reduction in odds of opioid misuse compared to blister packs only (OR = 0.08, p = 0.03). Relative risk estimation by log-binomial regression also revealed that patients in the control group were at 7 times higher risk of opioid misuse than those using the CPMRx app (Wald χ2 = 3.82, RR = 7.00, p = 0.05). Among the 21 participants in Phase I who did not misuse their prescription opioids, the average number of pills used was 2.7 (SD = 3.5); 95% of patients used 8 or fewer pills, 90% used 6 or fewer, 75% used 4 or fewer, and half of participants used 1 or fewer opioids. Conclusions Women using the CPMRx mobile application were less likely to misuse their prescription opioids during the postoperative period following cesarean section. A prescription of 7 tablets of 5 mg oxycodone may be a more appropriate prescription size among this group. Systematically right-sizing prescriptions, including for subgroups, may decrease both patient- and community-level risk of opioid misuse and reduce public health burden. Trial registration The study was registered at ClinicalTrials.gov (NCT05461196, 18/07/2022). |
| format | Article |
| id | doaj-art-46fed0f6861e4eacab22dbaaa2cc2ff6 |
| institution | OA Journals |
| issn | 1471-2393 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Pregnancy and Childbirth |
| spelling | doaj-art-46fed0f6861e4eacab22dbaaa2cc2ff62025-08-20T02:20:44ZengBMCBMC Pregnancy and Childbirth1471-23932024-12-012411810.1186/s12884-024-06953-7Evaluation of a mobile application to decrease opioid misuse in patients undergoing cesarean section: a randomized controlled trialAnnabelle Abdo0Mariel O’Connor1Jessica Kelley Morgan2Laura Hart3Alexa Leib4Steven K. Walther5Andy Tang6Gail Herrine7Department of Obstetrics, Gynecology and Reproductive Sciences, Temple University Lewis Katz School of MedicineDepartment of Obstetrics, Gynecology and Reproductive Sciences, Temple University Lewis Katz School of MedicineContinuous Precision MedicineDepartment of Obstetrics, Gynecology and Reproductive Sciences, Temple University Lewis Katz School of MedicineDepartment of Obstetrics, Gynecology and Reproductive Sciences, Temple University Lewis Katz School of MedicineContinuous Precision MedicineDepartment of Obstetrics, Gynecology and Reproductive Sciences, Temple University Lewis Katz School of MedicineDepartment of Obstetrics, Gynecology and Reproductive Sciences, Temple University Lewis Katz School of MedicineAbstract Background Opioid misuse and addiction are at epidemic levels in the United States. Postoperative opioid prescription is inconsistent and often excessive, including for cesarean section patients. Technology, such as mobile applications and clinical decision support tools, can be used to decrease opioid use and misuse among patients, and to determine more appropriate prescribing practices for specific procedures. The objective of this study was to examine the preliminary impact of the Continuing Precision Medicine (CPM) mobile application to reduce the use of opioid pain medication among women who underwent cesarean section. The primary outcome is morphine milligram equivalents (MME), while the secondary outcomes will be delay to dosages, decrease of usage, and pain scores. Methods Patients undergoing cesarean section were randomized to either a control group or an experimental group, which used the CPMRx mobile app to help manage postoperative pain. Logistic regression analyses were run to predict opioid misuse by group (control [electronic monitoring blister pack only] versus CPMRx [electronic monitoring blister pack plus mobile application]) and odds ratios (ORs) were calculated. Relative risk (RR) was also estimated by log-binomial regression. Results In phase I, 105 patients were assessed for eligibility, however, 66 were excluded (not meeting criteria or declined to participate). In phase 2, 98 patients were assessed for eligibility, however, 48 were excluded for the aforementioned. Results of the logistic regression showed that opioid misuse differed significantly by group (χ2 = 7.27, p = 0.007) with participants in the CPMRx group experiencing a 92% reduction in odds of opioid misuse compared to blister packs only (OR = 0.08, p = 0.03). Relative risk estimation by log-binomial regression also revealed that patients in the control group were at 7 times higher risk of opioid misuse than those using the CPMRx app (Wald χ2 = 3.82, RR = 7.00, p = 0.05). Among the 21 participants in Phase I who did not misuse their prescription opioids, the average number of pills used was 2.7 (SD = 3.5); 95% of patients used 8 or fewer pills, 90% used 6 or fewer, 75% used 4 or fewer, and half of participants used 1 or fewer opioids. Conclusions Women using the CPMRx mobile application were less likely to misuse their prescription opioids during the postoperative period following cesarean section. A prescription of 7 tablets of 5 mg oxycodone may be a more appropriate prescription size among this group. Systematically right-sizing prescriptions, including for subgroups, may decrease both patient- and community-level risk of opioid misuse and reduce public health burden. Trial registration The study was registered at ClinicalTrials.gov (NCT05461196, 18/07/2022).https://doi.org/10.1186/s12884-024-06953-7ObstetricsOpioid misusePrescriptionCesarean sectionSubstance usePrimary prevention |
| spellingShingle | Annabelle Abdo Mariel O’Connor Jessica Kelley Morgan Laura Hart Alexa Leib Steven K. Walther Andy Tang Gail Herrine Evaluation of a mobile application to decrease opioid misuse in patients undergoing cesarean section: a randomized controlled trial BMC Pregnancy and Childbirth Obstetrics Opioid misuse Prescription Cesarean section Substance use Primary prevention |
| title | Evaluation of a mobile application to decrease opioid misuse in patients undergoing cesarean section: a randomized controlled trial |
| title_full | Evaluation of a mobile application to decrease opioid misuse in patients undergoing cesarean section: a randomized controlled trial |
| title_fullStr | Evaluation of a mobile application to decrease opioid misuse in patients undergoing cesarean section: a randomized controlled trial |
| title_full_unstemmed | Evaluation of a mobile application to decrease opioid misuse in patients undergoing cesarean section: a randomized controlled trial |
| title_short | Evaluation of a mobile application to decrease opioid misuse in patients undergoing cesarean section: a randomized controlled trial |
| title_sort | evaluation of a mobile application to decrease opioid misuse in patients undergoing cesarean section a randomized controlled trial |
| topic | Obstetrics Opioid misuse Prescription Cesarean section Substance use Primary prevention |
| url | https://doi.org/10.1186/s12884-024-06953-7 |
| work_keys_str_mv | AT annabelleabdo evaluationofamobileapplicationtodecreaseopioidmisuseinpatientsundergoingcesareansectionarandomizedcontrolledtrial AT marieloconnor evaluationofamobileapplicationtodecreaseopioidmisuseinpatientsundergoingcesareansectionarandomizedcontrolledtrial AT jessicakelleymorgan evaluationofamobileapplicationtodecreaseopioidmisuseinpatientsundergoingcesareansectionarandomizedcontrolledtrial AT laurahart evaluationofamobileapplicationtodecreaseopioidmisuseinpatientsundergoingcesareansectionarandomizedcontrolledtrial AT alexaleib evaluationofamobileapplicationtodecreaseopioidmisuseinpatientsundergoingcesareansectionarandomizedcontrolledtrial AT stevenkwalther evaluationofamobileapplicationtodecreaseopioidmisuseinpatientsundergoingcesareansectionarandomizedcontrolledtrial AT andytang evaluationofamobileapplicationtodecreaseopioidmisuseinpatientsundergoingcesareansectionarandomizedcontrolledtrial AT gailherrine evaluationofamobileapplicationtodecreaseopioidmisuseinpatientsundergoingcesareansectionarandomizedcontrolledtrial |